home / stock / awknf / awknf quote
Last: | $0.075 |
---|---|
Change Percent: | -5.06% |
Open: | $0.075 |
Close: | $0.079 |
High: | $0.075 |
Low: | $0.075 |
Volume: | 7,000 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.075 | $0.075 | $0.079 | $0.075 | $0.075 | 7,000 | 07-05-2024 |
$0.079 | $0.075 | $0.079 | $0.079 | $0.075 | 1,350 | 07-04-2024 |
$0.079 | $0.075 | $0.079 | $0.079 | $0.075 | 1,350 | 07-03-2024 |
$0.075 | $0.075 | $0.075 | $0.075 | $0.075 | 2,460 | 07-02-2024 |
$0.075 | $0.075 | $0.075 | $0.075 | $0.075 | 5,000 | 06-27-2024 |
$0.07325 | $0.0745 | $0.07325 | $0.0745 | $0.07325 | 1,455 | 06-26-2024 |
$0.0762 | $0.072 | $0.0762 | $0.0762 | $0.072 | 6,500 | 06-25-2024 |
$0.0715 | $0.1004 | $0.0715 | $0.1004 | $0.07 | 27,000 | 06-21-2024 |
$0.08 | $0.0897 | $0.08 | $0.0897 | $0.08 | 5,500 | 06-20-2024 |
$0.0856 | $0.08775 | $0.0856 | $0.0878 | $0.0856 | 350 | 06-19-2024 |
$0.0856 | $0.08775 | $0.0856 | $0.08775 | $0.0856 | 350 | 06-18-2024 |
$0.0824 | $0.0824 | $0.0824 | $0.0824 | $0.0824 | 100 | 06-17-2024 |
$0.0837 | $0.095 | $0.0837 | $0.09935 | $0.0837 | 32,495 | 06-13-2024 |
$0.1 | $0.1 | $0.1 | $0.1 | $0.1 | 550 | 06-12-2024 |
$0.089 | $0.1035 | $0.089 | $0.1035 | $0.089 | 2,852 | 06-10-2024 |
$0.091 | $0.0981 | $0.091 | $0.0981 | $0.091 | 15,936 | 06-07-2024 |
$0.1 | $0.1042 | $0.1 | $0.1042 | $0.1 | 2,899 | 06-06-2024 |
$0.091 | $0.0977 | $0.091 | $0.11 | $0.09 | 7,040 | 06-05-2024 |
$0.12 | $0.11 | $0.12 | $0.12 | $0.11 | 16,464 | 06-04-2024 |
$0.11 | $0.11 | $0.11 | $0.11 | $0.11 | 10,500 | 06-03-2024 |
News, Short Squeeze, Breakout and More Instantly...
Toronto, Ontario--(Newsfile Corp. - May 2, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder (AUD), annou...
Toronto, Ontario--(Newsfile Corp. - April 17, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder (AUD), is ...
Awakn also announces Private Placement Toronto, Ontario--(Newsfile Corp. - April 3, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term f...